Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

25 Mar 2019 07:00

RNS Number : 7798T
Standard Life Private Eqty Trst PLC
25 March 2019
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") decreased by 0.5% to 428.2 pence for the quarter ended 31 December 2018

· Realised gains and income on the unquoted portfolio during the quarter ended 31 December 2018 totalled £11.3 million (1.7% of NAV). The unrealised loss on a constant exchange rate basis was 11.4 million (1.7% of NAV). In addition, there were unrealised foreign exchange gains of £4.9 million (0.7% of NAV)

· The final quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 25 January 2019

· 99.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2018

· NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018

· Outstanding commitments were £385.6 million at 31 December 2018

· Resources available for investment were £95.6 million at 31 December 2018

 

For the quarter ended 31 December 2018, the Company's NAV decreased by 0.5% to 428.2 pence per share, from 430.2 pence per share at 30 September 2018. At 31 December 2018, the Company's net assets were £658.3 million (30 September 2018 - £661.4 million). NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018.

 

The closing value of the Company's unquoted portfolio, which, included 55 private equity fund interests, was £562.1 million at 31 December 2018 (30 September 2018 - £574.7 million and 55 private equity fund interests). The total unrealised loss on the unquoted portfolio for the quarter ended 31 December 2018 was £6.5 million, comprising £11.4 million of unrealised loss on a constant exchange rate basis and £4.9 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) both fell by 11% during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.8% and 2.3% respectively, relative to sterling over the quarter.

 

During the quarter ended 31 December 2018, the unquoted portfolio generated £28.7 million of distributions (quarter ended 30 September 2018 - £24.4 million). The Company funded £11.4 million of drawdowns (quarter ended 30 September 2018 - £31.0 million) into the unquoted portfolio. The distributions received during the quarter generated £11.3 million of net realised gains and income. The net realised gains and income include the realised loss on written-off investments which were previously already recognised within unrealised losses. Excluding the realised loss on written-off investments, the net realised gains and income was £17.1 million. This was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €30.0 million to Triton V. The Company had total outstanding commitments to its 55 private equity fund interests of £385.6 million at 31 December 2018 (30 September 2018 - £369.3 million to 55 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2018, the Company had resources available for investment of £95.6 million (30 September 2018 - resources available for investment of £86.5 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 31 December 2018

 

On 25 January 2019, the Company paid the final dividend for the year ended 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8m. In addition, the Company declared a first quarter dividend for the year ending 30 September 2019 of 3.2 pence per share, to be paid on 26 April 2019, to shareholders on the Company's share register as at 22 March 2019. The ex-dividend date is 21 March 2019.

 

During the period from the 1 January 2019 to the 8 March 2019 the Company funded £14.2 million of drawdowns and received £11.8 million of distributions.

 

A new commitment of €35m was made to Altor V on 6 February 2019, and a new co- investment commitment of €6m was made to Mademoiselle Desserts, alongside IK Investment Partners, on 15 February 2019.

 

At 8 March 2019, the Company had resources available for investment of £90.6 million. The Company also had total outstanding commitments of £394.0 million.

 

The Company's estimated NAV at 28 February 2019 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2019 on or around 19 June 2019.

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTELLFLKXFZBBQ
Date   Source Headline
10th Apr 201410:41 amRNSHolding(s) in Company
2nd Apr 201410:07 amRNSDirector Declaration
1st Apr 201411:39 amRNSTotal Voting Rights
19th Mar 20147:00 amRNSQuarterly Trading Statement
3rd Mar 201410:00 amRNSTotal Voting Rights
3rd Feb 201412:20 pmRNSTransaction in Own Shares
3rd Feb 201410:58 amRNSTotal Voting Rights
29th Jan 20144:05 pmRNSTransaction in Own Shares
28th Jan 20142:29 pmRNSHolding(s) in Company
28th Jan 20142:27 pmRNSInterim Management Statement
28th Jan 20142:22 pmRNSResult of AGM
24th Jan 20144:41 pmRNSTransaction in Own Shares
2nd Jan 201412:01 pmRNSQuarterly Disclosure
2nd Jan 201411:59 amRNSTotal Voting Rights
31st Dec 20139:55 amRNSApplication for Listing
11th Dec 20134:51 pmRNSTransaction in Own Shares
4th Dec 20134:31 pmRNSAnnual Financial Report
28th Nov 20137:00 amRNSPreliminary Results
31st Oct 20132:40 pmRNSApplication for Listing
1st Oct 20139:57 amRNSQuarterly Disclosure
23rd Sep 201311:48 amRNSDirector Declaration
18th Sep 20137:00 amRNSQuarterly Trading Statement
1st Aug 20137:30 amRNSTotal Voting Rights
11th Jul 20136:14 pmRNSHolding(s) in Company
8th Jul 201312:28 pmRNSInterim Management Statement
1st Jul 201310:58 amRNSQuarterly Disclosure
28th Jun 201311:46 amRNSApplication for Listing
21st Jun 20139:47 amRNSDirector Declaration
11th Jun 20134:03 pmRNSDirectorate Change
3rd Jun 20131:58 pmRNSDirectorate Change
29th May 20135:00 pmRNSHalf Yearly Report
2nd Apr 201311:43 amRNSQuarterly Disclosure
2nd Apr 201311:40 amRNSTotal Voting Rights
26th Mar 20134:58 pmRNSTransaction in Own Shares
20th Mar 20134:05 pmRNSDirector/PDMR Shareholding
20th Mar 20137:00 amRNSQuarterly Trading Statement
18th Mar 20133:25 pmRNSHolding(s) in Company
8th Feb 20132:41 pmRNSDirector/PDMR Shareholding
5th Feb 20131:20 pmRNSDirector/PDMR Shareholding
1st Feb 201311:33 amRNSTotal Voting Rights
29th Jan 20134:37 pmRNSInterim Management Statement
29th Jan 20131:52 pmRNSIssue of Equity
29th Jan 20131:48 pmRNSResult of AGM
29th Jan 20131:47 pmRNSDirectorate Changes
9th Jan 20134:29 pmRNSScrip dividend reference price
4th Jan 201312:22 pmRNSQuarterly Disclosure
3rd Jan 201311:21 amRNSDirector/PDMR Shareholding
31st Dec 20128:00 amRNSApplication for Listing
31st Dec 20128:00 amRNSDebt Facility
14th Dec 201212:15 pmRNSDoc re. Annual Report and Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.